Reversible Valproic Acid‐Induced Dementia: A Case Report
- 1 June 1986
- Vol. 27 (3) , 234-240
- https://doi.org/10.1111/j.1528-1157.1986.tb03534.x
Abstract
Reversible valproic acid-induced dementia was documented in a 21-year-old man with epilepsy who had a 3-year history of insidious progressive decline in global cognitive abilities documented by serial neuropsychological studies. Repeat neuropsychological testing 7 weeks after discontinuation of the drug revealed dramatic improvement in IQ, memory, naming, and other tasks commensurate with clinical recovery in his intellectual capacity. Possible pathophysiological mechanisms which may have been operative in this case include: a direct central nervous system (CNS) toxic effect of valproic acid; a paradoxical epileptogenic effect secondary to the drug; and an indirect CNS toxic effect mediated through valproic acid-induced hyperammonemia.Keywords
This publication has 45 references indexed in Scilit:
- Effect of Associated Antiepileptic Treatment on Valproate-Induced HyperammonemiaTherapeutic Drug Monitoring, 1985
- Adverse Effects of ValproateEpilepsia, 1984
- Effectiveness and Toxicity of Phenobarbital, Primidone, and Sodium Valproate in the Prevention of Febrile Convulsions, Controlled by Plasma LevelsEpilepsia, 1984
- Hyperammonemia and Valproate-Induced Alterations of the State of ConsciousnessEuropean Neurology, 1984
- Carnitine deficiency and hyperammonemia associated with valproic acid therapyThe Journal of Pediatrics, 1982
- Changes in Seizure Frequency and Test‐Retest Scores on the Wechsler Adult Intelligence ScaleEpilepsia, 1981
- Cerebral Dysfunction in Asymptomatic Carriers of Ornithine Transcarbamylase DeficiencyNew England Journal of Medicine, 1980
- Treatment of accidental sodium valproate overdose with an opiate antagonistAnnals of Neurology, 1979
- Platelet transfusions.BMJ, 1971
- Psychological Changes Associated with Induced HyperammonemiaScience, 1964